Clinical Trial Update: The Effect of Curcumin on Inflammatory Markers in Hemodialysis Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the effect of curcumin on inflammatory markers in adults receiving hemodialysis; currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• Curcumin (curcumin)

Snippet

Sponsor: University of Guadalajara | Conditions: Hemodialysis | Phase 2 | Status: NOT_YET_RECRUITING